Detalles de la búsqueda
1.
Opioid Use Disorder Treatments: An Evidence Map.
Drug Alcohol Depend
; 241: 109657, 2022 Dec 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-36332588
2.
Perceptions and experiences toward extended-release buprenorphine among persons leaving jail with opioid use disorders before and during COVID-19: an in-depth qualitative study.
Addict Sci Clin Pract
; 17(1): 4, 2022 01 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-35093164
3.
Exploring nonprescribed use of buprenorphine in the criminal justice system through qualitative interviews among individuals recently released from incarceration.
J Subst Abuse Treat
; 123: 108267, 2021 04.
Artículo
en Inglés
| MEDLINE | ID: mdl-33612198
4.
Use of non-prescribed buprenorphine in the criminal justice system: Perspectives of individuals recently released from incarceration.
J Subst Abuse Treat
; 127: 108349, 2021 08.
Artículo
en Inglés
| MEDLINE | ID: mdl-34134866
5.
Comparison of Treatment Retention of Adults With Opioid Addiction Managed With Extended-Release Buprenorphine vs Daily Sublingual Buprenorphine-Naloxone at Time of Release From Jail.
JAMA Netw Open
; 4(9): e2123032, 2021 09 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-34495340
6.
Long-acting buprenorphine vs. naltrexone opioid treatments in CJS-involved adults (EXIT-CJS).
J Subst Abuse Treat
; 128: 108389, 2021 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-33865691
7.
Extended-release vs. oral naltrexone for alcohol dependence treatment in primary care (XON).
Contemp Clin Trials
; 81: 102-109, 2019 06.
Artículo
en Inglés
| MEDLINE | ID: mdl-30986535
Resultados
1 -
7
de 7
1
Próxima >
>>